The Deerborne Group
“Photo Credit: Shutterstock.com” Have you ever wondered why certain biotech companies consistently thrive while others face challenges year after year? Although numerous factors contribute to this phenomenon, a crucial aspect that stands out is their failure to prioritize the early…
Read More
“Photo Credit: Shutterstock.com” Since the earliest map of the human genome was first completed, in 2003, applications of genetic testing have increased exponentially in both research and clinical settings. A 2018 study funded by the National Human Genome Research Institute…
Read More
“Photo Credit: Shutterstock.comâ€Â At the end of the day, people just want to be happy. Especially these days. Sure, they also want to be safe and prosperous. That goes without saying. But one of the ways that people derive happiness…
Read More
“Photo Credit: Shutterstock.com†Gone are the days of Ozzie and Harriet when life was simple, wholesome, and easily understood. In today’s society, where basically everyone is influenced by the internet and what they read or see on social media,¹companies are…
Read More
“Photo Credit: Shutterstock.com” Startups are known for being some of the biggest disruptors within the broader life science sector — creating new and innovative technologies to diagnose, treat, and monitor a vast array of critical diseases. However, some seventy-five percent…
Read More
“Photo Credit: Shutterstock.com” It would be an understatement to say that the global COVID pandemic caught the world by surprise. In 2020, the coronavirus pandemic sent the world into a recession and sent equity markets reeling as the S&P 500…
Read More
“Photo Credit: Shutterstock.com” In this blog, Jeffrey Jones, Managing Partner at The Deerborne Group, takes a brief lookback at the origins and associated key milestones related to the initial spread of the COVID-19 global pandemic. Since December 12, 2019, when a cluster…
Read More
“Photo Credit: Shutterstock.com” By now, most everyone is tired of talking about the global coronavirus pandemic. However, it has caused a significant impact on European healthcare budgets while shifting the attention and resources toward COVID-19 research. The soaring drug spending…
Read More